AU Patent

AU2018343545B2 — Intranasal delivery devices

Assigned to Shin Nippon Biomedical Laboratories Ltd · Expires 2024-02-08 · 2y expired

What this patent protects

The present disclosure provides devices for delivery of powder formulations and methods of manufacture and use of such devices.

USPTO Abstract

The present disclosure provides devices for delivery of powder formulations and methods of manufacture and use of such devices.

Drugs covered by this patent

Patent Metadata

Patent number
AU2018343545B2
Jurisdiction
AU
Classification
—
Expires
2024-02-08
Drug substance claim
No
Drug product claim
No
Assignee
Shin Nippon Biomedical Laboratories Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.